Different signaling pathways expressed by chicken naïve CD4 + T cells, CD4 + lymphocytes activated with staphylococcal enterotoxin B, and those malignantly transformed by marek's disease virus

Journal of Proteome Research

Volumn 7, Issue 6, 2008, Pages 2380-2387

  Buza, Joram J ^a   Burgess, Shane C ^a,b,c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

^c MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

CD4 + T cells; Differential proteomics; Enterotoxin B; Lymphoma; Marek's disease; MudPIT; Pathwaystudio; Shotgun proteomics; Staphylococcus

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; GROWTH FACTOR; PROTEOME; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN; TRANSCRIPTION FACTOR; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; HLA ANTIGEN CLASS 2; SIGNAL PEPTIDE;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; COMPUTER PROGRAM; LYMPHOCYTE TRANSFORMATION; MALIGNANT TRANSFORMATION; MARDIVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; T CELL LYMPHOMA; ANIMAL; CELL LINE; CHICKEN; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; FLOW CYTOMETRY; LIQUID CHROMATOGRAPHY; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY; PHYSIOLOGY; PROTEIN DATABASE; TANDEM MASS SPECTROMETRY; VIROLOGY;

ANIMALIA; GALLID HERPESVIRUS 2; STAPHYLOCOCCUS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CHICKENS; CHROMATOGRAPHY, LIQUID; DATABASES, PROTEIN; ENTEROTOXINS; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; MARDIVIRUS; PROTEOMICS; SIGNAL TRANSDUCTION; SOFTWARE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 49849092309     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr700844z     Document Type: Article

References (49)

1. Gygi, S. P.; Corthals, G. L.; Zhang, Y.; Rochon, Y.; Aebersold, R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc. Natl. Acad. Sci. U.S.A. 2000, 97 (17), 9390-5.
2. Baggerman, G.; Vierstraete, E.; De Loof, A.; Schoofs, L. Gel-based versus gel-free proteomics: a review. Comb. Chem. High Throughput Screening 2005, 8 (8), 669-77.
3. Monteoliva, L.; Albar, J. P. Differential proteomics: an overview of gel and non-gel based approaches. Briefings Funct. Genomics Proteomics 2004, 3 (3), 220-39.
4. Tan, F. K.; Hildebrand, B. A.; Lester, M. S.; Stivers, D. N.; Pounds, S.; Zhou, X.; Wallis, D. D.; Milewicz, D. M; Reveille, J. D.; Mayes, M. D.; Jin, L.; Arnett, F. C., Jr. Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease. Arthritis Rheum. 2005, 52 (3), 865-76.
5. Zhou, X.; Tan, F. K.; Xiong, M.; Arnett, F. C.; Feghali-Bostwick, C. A. Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles. Arthritis Rheum. 2005, 52 (10), 3305-14.
6. Tan, F. K.; Zhou, X.; Mayes, M. D.; Gourh, P.; Guo, X.; Marcum, C; Jin, L.; Arnett, F. C., Jr. Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) 2006, 45 (6), 694-702.
7. Attwood, T. K. Genomics. The Babel of bioinformatics. Science 2000, 290 (5491), 471-3.
8. Yuryev, A.; Mulyukov, Z.; Kotelnikova, E.; Maslov, S.; Egorov, S.; Nikitin, A.; Daraselia, N.; Mazo, I. Automatic pathway building in biological association networks. BMC Bioinf. 2006, 7, 171.
9. Wang, J.; Robinson, J. F.; O'Neil, C. H.; Edwards, J. Y.; Williams, C. M.; Huff, M. W.; Pickering, J. G.; Hegele, R. A. Ankyrin G overexpression in Hutchinson-Gilford progeria syndrome fibroblasts identified through biological filtering of expression profiles. J. Hum. Genet. 2006, 51 (11), 934-42.
10. Buza, J. J.; Burgess, S. C. Modeling the proteome of a Marek's disease transformed cell line: a natural animal model for CD30 overexpressing lymphomas. Proteomics 2007, 7(8), 1316-26.
11. Burgess, S. C.; Davison, T. F. Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37. J. Virol. 2002, 76 (14), 7276-92.
12. Burgess, S. C.; Young, J. R.; Baaten, B. J.; Hunt, L.; Ross, L. N.; Parcells, M. S.; Kumar, P. M.; Tregaskes, C. A.; Lee, L. F.; Davison, T. F. Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30). Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (38), 13879-84.
13. Dienglewicz, R. L.; Parcells, M. S. Establishment of a lymphoblas-toid cell line using a mutant MDV containing a green fluorescent protein expression cassette. Acta Virol. 1999, 43 (2-3), 106-12.
14. McCormick, J. K.; Yarwood, J. M.; Schlievert, P. M. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 2001, 55, 77-104.
15. Chatila, T.; Geha, R. S. Signal transduction by microbial superantigens via MHC class II molecules. Immunol. Rev. 1993, 131, 43-59.
16. Krakauer, T. Chemotherapeutics targeting immune activation by staphylococcal superantigens. Med. Sci. Monit. 2005, 11 (9), RA290-5.
17. McCarthy, F. M.; Burgess, S. C; van den Berg, B. H.; Koter, M. D.; Pharr, G. T. Differential detergent fractionation for non-electro-phoretic eukaryote cell proteomics. J. Proteome Res. 2005, 4 (2), 316-24.
18. MacCoss, M. J.; Wu, C. C.; Yates, J. R., III. Probability-based validation of protein identifications using a modified SEQUEST algorithm. Anal. Chem. 2002, 74 (21), 5593-9.
19. Yates, J. R., III; Eng, J. K.; McCormack, A. L. Mining genomes: correlating tandem mass spectra of modified and unmodified peptides to sequences in nucleotide databases. Anal. Chem. 1995, 67 (18), 3202-10.
20. Durr, E.; Yu, J.; Krasinska, K. M.; Carver, L. A.; Yates, J. R.; Testa, J. E.; Oh, P.; Schnitzer, J. E. Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat. Biotechnol. 2004, 22 (8), 985-92.
21. Mannie, M. D.; Dawkins, J. G.; Walker, M. R.; Clayson, B. A.; Patel, D. M. MHC class II biosynthesis by activated rat CD4+ T cells: development of repression in vitro and modulation by APC-derived signals. Cell Immunol. 2004, 230 (1), 33-43.
22. Fraser, J. D.; Newton, M. E.; Weiss, A. CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation. J Exp Med 1992, 175 (4), 1131-4.
23. Liu, J.; Wu, C. Y. [Subpopulations and cytokine expression of naive and memory T cells in normal human PBMCs.]. Xibao Yu Fenzi Mianyixue Zazhi 2007, 23 (1), 2-5.
24. Krueger, A.; Fas, S. C.; Baumann, S.; Krammer, P. H. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol. Rev. 2003, 193, 58-69.
25. Green, D. R.; Droin, N.; Pinkoski, M. Activation-induced cell death in T cells. Immunol. Rev. 2003, 193, 70-81.
26. Arnold, R.; Brenner, D.; Becker, M.; Frey, C. R.; Krammer, P. H. How T lymphocytes switch between life and death. Eur. J. Immunol. 2006, 36 (7), 1654-8.
27. Kurella, S.; Yaciuk, J. C; Dozmorov, I.; Frank, M. B.; Centola, M.; Farris, A. D. Transcriptional modulation of TCR, Notch and Wnt signaling pathways in SEB-anergized CD4+ T cells. Genes Immun. 2005, 6 (7), 596-608.
28. Baron, M. An overview of the Notch signalling pathway. Semin. Cell Dev. Biol. 2003, 14 (2), 113-9.
29. Goustin, A. S.; Leof, E. B.; Shipley, G. D.; Moses, H. L. Growth factors and cancer. Cancer Res. 1986, 46 (3), 1015-29.
30. Sporn, M. B.; Roberts, A. B. Autocrine growth factors and cancer. Nature 1985, 313 (6005), 745-7.
31. Breuhahn, K.; Longerich, T.; Schirmacher, P. Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene 2006, 25 (27), 3787-800.
32. Sun, S.; Schiller, J. H. Angiogenesis inhibitors in the treatment of lung cancer. Crit. Rev. Oncol. Hematol. 2007, 62 (2), 93-104.
33. Zetter, B. R. Cell motility in angiogenesis and tumor metastasis. Cancer Invest. 1990, 8 (6), 669-71.
34. Sooriakumaran, P.; Kaba, R. Angiogenesis and the tumour hypoxia response in prostate cancer: a review. Int. J. Surg. 2005, 3 (1), 61-7.
35. Kermani, P.; Hempstead, B. Brain-derived neurotrophic factor: a newly described mediator of angiogenesis. Trends Cardiovasc. Med. 2007, 17 W, 140-3.
36. Malcangio, M.; Garrett, N. E.; Cruwys, S.; Tomlinson, D. R. Nerve growth factor- and neurotrophin-3-induced changes in nociceptive threshold and the release of substance P from the rat isolated spinal cord. J. Neurosci. 1997, 17 (21), 8459-67.
37. Payne, L. N.; Frazier, J. A.; Powell, P. C. Pathogenesis of Marek's disease. Int. Rev. Exp. Pathol. 1976, 16, 59-154.
38. Gresser, I.; Belardelli, F. Endogenous type I interferons as a defense against tumors. Cytokine Growth Factor Rev. 2002, 13 (2), 111-8.
39. Smyth, M. J.; Cretney, E.; Kershaw, M. H.; Hayakawa, Y. Cytokines in cancer immunity and immunotherapy. Immunol. Rev. 2004, 202, 275-93.
40. Ohm, J. E.; Carbone, D. P. VEGF as a mediator of tumor-associated immunodeficiency. Immunol. Res. 2001, 23 (2-3), 263-72.
41. Siegel, P. M.; Massague, J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 2003, 3 (11), 807-21.
42. Gotzmann, J.; Huber, H.; Thallinger, C.; Wolschek, M.; Jansen, B.; Schulte-Hermann, R.; Beug, H.; Mikulits, W. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-betal and Ha-Ras: steps towards invasiveness. J. Cell Sci. 2002, 115 (Pt 6), 1189-202.
43. Shack, A. L.; Buza, J. J.; Burgess, S. C., The neoplastically transformed (CD30hi) Marek's disease lymphoma cell phenotype most closely resembles T-regulatory cells. Cancer Immunol. Immu-nother. 2008, in press.
44. Weyant, M. J.; Carothers, A. M.; Bertagnolli, M. E.; Bertagnolli, M. M. Colon cancer chemopreventive drugs modulate integrin-mediated signaling pathways. Clin. Cancer Res. 2000, 6 (3), 949-56.
45. Ashcom, G.; Gurland, G.; Schwartz, J. Growth hormone synergizes with serum growth factors in inducing c-fos transcription in 3T3-F442A cells. Endocrinology 1992, 131 (4), 1915-21.
46. Milde-Langosch, K. The Fos family of transcription factors and their role in tumourigenesis. Eur. J. Cancer 2005, 41 (16), 2449-61.
47. Sassone-Corsi, P. Signaling pathways and c-fos transcriptional responses-links to inherited diseases. N. Engl. J. Med. 1995, 332 (23), 1576-7.
48. Dontu, G.; Jackson, K. W.; McNicholas, E.; Kawamura, M. J.; Abdallah, W. M.; Wicha, M. S. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. 2004, 6 (6), R605-15.
49. Peduto Eberl, L.; Bovey, R.; Juillerat-Jeanneret, L. Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells. Br. J. Cancer 2003, 88 (5), 788-95.